Literature DB >> 34628477

Increasing awareness of degenerative cervical myelopathy: a preventative cause of non-traumatic spinal cord injury.

Carl M Zipser1, Konstantinos Margetis2, Karlo M Pedro3, Armin Curt4, Michael Fehlings5, Iwan Sadler6, Lindsay Tetreault7, Benjamin M Davies8.   

Abstract

Degenerative cervical myelopathy (DCM) is a common non-traumatic spinal cord disorder and characterized by progressive neurological impairment. Generally, it is still underdiagnosed and referral to spine specialists is often late, when patients already present with incomplete cervical spinal cord injury (SCI). To improve early diagnosis and accelerate referral, diagnostic criteria for DCM are required. Recently, AO Spine RECODE- DCM (REsearch Objectives and Common Data Elements for Degenerative Cervical Myelopathy) (aospine.org/recode), an international, interdisciplinary and interprofessional initiative, including patients with DCM, was funded with the aim to accelerate knowledge discovery that can change outcomes. In this perspective we advocate for the participation of SCI specialists in this process, where the expertise and perspective on this disorder and requirements for the diagnostic and therapeutic work up is well developed.
© 2021. The Author(s).

Entities:  

Mesh:

Year:  2021        PMID: 34628477      PMCID: PMC8560634          DOI: 10.1038/s41393-021-00711-8

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


Perspective

Degenerative cervical myelopathy (DCM) (historically termed “cervical spondylotic myelopathy” [CSM]) is the most common non-traumatic, progressive spinal cord disorder with an estimated 2% prevalence [1]. The disorder is indeed imprecisely and insufficiently characterized by neck and radicular pain, fine motor dysfunction, gait instability, and bladder dysfunction and for most lacks common diagnostic criteria [2]. If not recognized and treated timely, patients may eventually present as incomplete cervical spinal cord injury (SCI). This letter aims to raise awareness of these shortcomings in the neurological community and emphasize an ongoing initiative to improve clinical care and foster global research [3]. The neurological field should not be left out in this effort. Due to a variety of symptoms, patients eventually get referred to different specialists, commonly orthopedics, neurosurgeons, neurologists, or physiotherapists. While surgical decompression of the encroached spinal cord is recommended in patients experiencing already moderate/severe, or progressive symptoms, the goal of enabling earlier and/or preventative treatment has now been defined as a priority research need. In its early stages, DCM is frequently underdiagnosed or misdiagnosed as carpal tunnel syndrome or peripheral neuropathy, until patients develop more severe impairments of upper and lower limb function urging the consideration of incomplete cervical SCI. Given that DCM is a progressive but preventable neurological condition, the delayed diagnosis and late referral for evaluation of surgical decompression, can lead to poorer neurological outcomes [4]. In addition, the pre-operative neurological status significantly influences post-operative recovery [5]. Therefore, an early diagnosis is important to achieve good clinical results. The diagnosis of DCM is currently based on clinical signs and symptoms, eventually complemented by cervical spine MRI. However, there is still no consensus on diagnostic criteria for DCM, leading to ambiguous, descriptive clinical diagnoses, and heterogenous definitions of DCM applied in clinical studies [6, 7]. Furthermore, as demonstrated in the UK, DCM is rarely covered in the medical curriculum [8]. AO Spine RECODE-DCM (REsearch Objectives and Common Data Elements for Degenerative Cervical Myelopathy) (aospine.org/recode) is an international, interdisciplinary, and interprofessional initiative, including patients with DCM, which aims to accelerate knowledge discovery that can change outcomes [9]. This has included the formation of research priorities such as the development of common diagnostic criteria. Alongside its importance for clinical care, a sensitive and specific set of diagnostic criteria is required to foster research, particularly for those studies aiming at investigating neuroprotective strategies. Diagnostic criteria for DCM can help to overcome several shortcomings in patient care and research (Fig. 1). The development of diagnostic criteria for DCM would benefit from the experiences of the neurological community; a UK cohort study identified 45% of cases are initially diagnosed by Neurologists, whilst Neurologists are familiar with their development and implementation [10]. Common criteria will help the dialog between neurologists, general practitioners (primary care providers), and spine specialists, and propagate the knowledge of red flags in DCM that require timely and specific actions, before established SCI. The development of diagnostic criteria involves both comprehensive diagnostic criteria for research and spine specialists, as well as easily applicable algorithms that speed up referral to cervical spine MRI and spine specialists. We have established an initial working group to act upon this opportunity (AO Spine RECODE DCM Diagnostic Criteria Incubator). If you are interested in contributing to this process, please contact us.
Fig. 1

Infographic providing an overview why diagnostic criteria for DCM are needed.

The panels summarize shortcomings in patient care and research which diagnostic criteria for DCM can help to overcome.

Infographic providing an overview why diagnostic criteria for DCM are needed.

The panels summarize shortcomings in patient care and research which diagnostic criteria for DCM can help to overcome.
  10 in total

Review 1.  Degenerative cervical myelopathy - update and future directions.

Authors:  Jetan H Badhiwala; Christopher S Ahuja; Muhammad A Akbar; Christopher D Witiw; Farshad Nassiri; Julio C Furlan; Armin Curt; Jefferson R Wilson; Michael G Fehlings
Journal:  Nat Rev Neurol       Date:  2020-01-23       Impact factor: 42.937

2.  A Clinical Prediction Rule for Functional Outcomes in Patients Undergoing Surgery for Degenerative Cervical Myelopathy: Analysis of an International Prospective Multicenter Data Set of 757 Subjects.

Authors:  Lindsay Tetreault; Branko Kopjar; Pierre Côté; Paul Arnold; Michael G Fehlings
Journal:  J Bone Joint Surg Am       Date:  2015-12-16       Impact factor: 5.284

3.  Diagnostic Delays Lead to Greater Disability in Degenerative Cervical Myelopathy and Represent a Health Inequality.

Authors:  Daniel H Pope; Oliver D Mowforth; Benjamin M Davies; Mark R N Kotter
Journal:  Spine (Phila Pa 1976)       Date:  2020-03-15       Impact factor: 3.468

Review 4.  The reporting of study and population characteristics in degenerative cervical myelopathy: A systematic review.

Authors:  Benjamin M Davies; M McHugh; A Elgheriani; Angelos G Kolias; Lindsay Tetreault; Peter J A Hutchinson; Michael G Fehlings; Mark R N Kotter
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

5.  Tackling Research Inefficiency in Degenerative Cervical Myelopathy: Illustrative Review.

Authors:  Danyal Zaman Khan; Muhammad Shuaib Khan; Mark Rn Kotter; Benjamin Marshall Davies
Journal:  JMIR Res Protoc       Date:  2020-06-11

6.  RE-CODE DCM (REsearch Objectives and Common Data Elements for Degenerative Cervical Myelopathy): A Consensus Process to Improve Research Efficiency in DCM, Through Establishment of a Standardized Dataset for Clinical Research and the Definition of the Research Priorities.

Authors:  Benjamin M Davies; Danyal Z Khan; Oliver D Mowforth; Angus G K McNair; Toto Gronlund; Angelos G Kolias; Lindsay Tetreault; Michelle L Starkey; Iwan Sadler; Ellen Sarewitz; Delphine Houlton; Julia Carter; Sukhvinder Kalsi-Ryan; Bizhan Aarabi; Brian K Kwon; Shekar N Kurpad; James Harrop; Jefferson R Wilson; Robert Grossman; Armin Curt; Michael G Fehlings; Mark R N Kotter
Journal:  Global Spine J       Date:  2019-05-08

7.  Route to diagnosis of degenerative cervical myelopathy in a UK healthcare system: a retrospective cohort study.

Authors:  Bryn Hilton; Jennifer Tempest-Mitchell; Benjamin Davies; Mark Kotter
Journal:  BMJ Open       Date:  2019-05-05       Impact factor: 2.692

8.  Quantitative analysis of medical students' and physicians' knowledge of degenerative cervical myelopathy.

Authors:  Mueez Waqar; Jane Wilcock; Jayne Garner; Benjamin Davies; Mark Kotter
Journal:  BMJ Open       Date:  2020-01-12       Impact factor: 2.692

9.  The Prevalence of Asymptomatic and Symptomatic Spinal Cord Compression on Magnetic Resonance Imaging: A Systematic Review and Meta-analysis.

Authors:  Sam S Smith; Max E Stewart; Benjamin M Davies; Mark R N Kotter
Journal:  Global Spine J       Date:  2020-06-24

Review 10.  Research activity amongst DCM research priorities.

Authors:  Ben Grodzinski; Harry Bestwick; Faheem Bhatti; Rory Durham; Maaz Khan; Celine Iswarya Partha Sarathi; Jye Quan Teh; Oliver Mowforth; Benjamin Davies
Journal:  Acta Neurochir (Wien)       Date:  2021-02-24       Impact factor: 2.216

  10 in total
  3 in total

1.  Correlation Analysis Between Magnetic Resonance Imaging-Based Anatomical Assessment and Behavioral Outcome in a Rat Contusion Model of Chronic Thoracic Spinal Cord Injury.

Authors:  Cong Xing; Zeyu Jia; Haodong Qu; Song Liu; Wang Jiang; Hao Zhong; Mi Zhou; Shibo Zhu; Guangzhi Ning; Shiqing Feng
Journal:  Front Neurosci       Date:  2022-04-21       Impact factor: 5.152

2.  Cerebrospinal fluid pressure dynamics reveal signs of effective spinal canal narrowing in ambiguous spine conditions.

Authors:  Najmeh Kheram; Nikolai Pfender; Andrea Boraschi; Mazda Farshad; Vartan Kurtcuoglu; Armin Curt; Martin Schubert; Carl M Zipser
Journal:  Front Neurol       Date:  2022-08-09       Impact factor: 4.086

3.  Proposing a Framework to Understand the Role of Imaging in Degenerative Cervical Myelopathy: Enhancement of MRI Protocols Needed for Accurate Diagnosis and Evaluation.

Authors:  Carl M Zipser; Michael G Fehlings; Konstantinos Margetis; Armin Curt; Michael Betz; Iwan Sadler; Lindsay Tetreault; Benjamin M Davies
Journal:  Spine (Phila Pa 1976)       Date:  2022-06-29       Impact factor: 3.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.